A Review: On Dexlansoprazole
Bhagyashree Bothe
, Dr.Krishna Murthy , Dr.R.V.Shete
Mechanism of Action Dexlansoprazole, Pharmacokinetics & Pharmacodynamics, pharmacological properties of dexlansoprazole, Indications for proton pump inhibitors therapy, treatment of gastroesophageal reflux disease.
The R-enantiomer of lansoprazole, dexlansoprazole, is delivered by a unique technology called the dual delayed release formulation. When compared to lansoprazole, the medicine has been demonstrated to be more effective at mending erosive esophagitis. Dexlansoprazole significantly improved the maintenance rates of repaired esophageal mucosa in patients with erosive esophagitis and symptom control in patients with non-erosive reflux syndrome when compared to placebo. Dexlansoprazole is a medication that can be given without concern for food. Overall, dexlansoprazole is well tolerated and has a side-effect profile that is similar to that of lansoprazole.
"A Review: On Dexlansoprazole", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.7, Issue 4, page no.135 - 142, April-2022, Available :https://ijsdr.org/papers/IJSDR2204024.pdf
Volume 7
Issue 4,
April-2022
Pages : 135 - 142
Paper Reg. ID: IJSDR_200181
Published Paper Id: IJSDR2204024
Downloads: 000347218
Research Area: Pharmacy
Country: KALAMBOLI, MAHARASHTRA, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
